Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
James Pense, D.O.
Family Practice · MOUNT DORA, FL · NPI 1962898775
Verified facts
What the public records show
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
Products named in Open Payments records
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 451 | 134 |
| Levothyroxine Sodium | Levothyroxine Sodium | 348 | 98 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 322 | 94 |
| Amlodipine Besylate | Amlodipine Besylate | 308 | 98 |
| Lisinopril | Lisinopril | 274 | 81 |
| Tamsulosin Hcl | Tamsulosin Hcl | 249 | 71 |
| Metformin Hcl | Metformin Hcl | 222 | 63 |
| Losartan Potassium | Losartan Potassium | 212 | 67 |
| Metoprolol Succinate | Metoprolol Succinate | 189 | 61 |
| Omeprazole | Omeprazole | 186 | 51 |
| Simvastatin | Simvastatin | 176 | 53 |
| Gabapentin | Gabapentin | 155 | 43 |
| Pioglitazone Hcl | Pioglitazone Hcl | 152 | 41 |
| Pantoprazole Sodium | Pantoprazole Sodium | 149 | 56 |
| Metoprolol Tartrate | Metoprolol Tartrate | 145 | 42 |
| Alprazolam | Alprazolam | 142 | 34 |
| Ozempic | Semaglutide | 139 | 28 |
| Hydrochlorothiazide | Hydrochlorothiazide | 136 | 45 |
| Allopurinol | Allopurinol | 125 | 34 |
| Tramadol Hcl | Tramadol Hcl | 119 | 30 |
| Prednisone | Prednisone | 104 | 70 |
| Furosemide | Furosemide | 103 | 37 |
| Synthroid | Levothyroxine Sodium | 102 | 23 |
| Fluticasone Propionate | Fluticasone Propionate | 99 | 34 |
| Trazodone Hcl | Trazodone Hcl | 96 | 28 |
| Ezetimibe | Ezetimibe | 83 | 27 |
| Pravastatin Sodium | Pravastatin Sodium | 80 | 25 |
| Metformin Hcl Er | Metformin Hcl | 79 | 28 |
| Jardiance | Empagliflozin | 70 | 17 |
| Pregabalin | Pregabalin | 65 | 16 |
| Potassium Chloride | Potassium Chloride | 64 | 20 |
| Meloxicam | Meloxicam | 63 | 20 |
| Baclofen | Baclofen | 61 | 29 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 56 | 47 |
| Carvedilol | Carvedilol | 56 | 18 |
| Duloxetine Hcl | Duloxetine Hcl | 56 | 20 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 52 | 15 |
| Eliquis | Apixaban | 50 | 17 |
| Zolpidem Tartrate | Zolpidem Tartrate | 50 | 12 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 49 | 13 |
| Celecoxib | Celecoxib | 49 | 15 |
| Clopidogrel | Clopidogrel Bisulfate | 49 | 20 |
| Montelukast Sodium | Montelukast Sodium | 49 | 14 |
| Sertraline Hcl | Sertraline Hcl | 47 | 13 |
| Atenolol | Atenolol | 44 | 13 |
| Citalopram Hbr | Citalopram Hydrobromide | 44 | 11 |
| Fluoxetine Hcl | Fluoxetine Hcl | 43 | 11 |
| Azithromycin | Azithromycin | 42 | 39 |
| Escitalopram Oxalate | Escitalopram Oxalate | 42 | 14 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 41 | suppressed |
| Telmisartan | Telmisartan | 40 | 14 |
| Finasteride | Finasteride | 39 | 13 |
| Spironolactone | Spironolactone | 38 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 37 | 13 |
| Anastrozole | Anastrozole | 36 | suppressed |
| Januvia | Sitagliptin Phosphate | 36 | suppressed |
| Temazepam | Temazepam | 36 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 35 | suppressed |
| Memantine Hcl | Memantine Hcl | 35 | 12 |
| Ibuprofen | Ibuprofen | 33 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 32 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 31 | 11 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 31 | suppressed |
| Glipizide Er | Glipizide | 29 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 29 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 29 | suppressed |
| Bupropion Xl | Bupropion Hcl | 28 | suppressed |
| Fenofibrate | Fenofibrate | 28 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 28 | suppressed |
| Lovastatin | Lovastatin | 27 | suppressed |
| Levemir Flexpen | Insulin Detemir | 26 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 26 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 25 | suppressed |
| Gemfibrozil | Gemfibrozil | 25 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 25 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 25 | suppressed |
| Glimepiride | Glimepiride | 24 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 24 | suppressed |
| Trulicity | Dulaglutide | 24 | suppressed |
| Lorazepam | Lorazepam | 23 | suppressed |
| Primidone | Primidone | 23 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 22 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 22 | 13 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 22 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 21 | 17 |
| Enalapril Maleate | Enalapril Maleate | 21 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 21 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 21 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 21 | suppressed |
| Irbesartan | Irbesartan | 20 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 20 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 19 | suppressed |
| Humulin 70/30 Kwikpen | Insulin Nph Hum/Reg Insulin Hm | 18 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 18 | suppressed |
| Methocarbamol | Methocarbamol | 18 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 18 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 18 | 18 |
| Ramipril | Ramipril | 18 | suppressed |
| Synjardy Xr | Empagliflozin/Metformin Hcl | 18 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 18 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 18 | 11 |
| Amitriptyline Hcl | Amitriptyline Hcl | 17 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 17 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 17 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 17 | suppressed |
| Famotidine | Famotidine | 17 | suppressed |
| Methylprednisolone | Methylprednisolone | 17 | 13 |
| Valsartan | Valsartan | 17 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 17 | suppressed |
| Naproxen | Naproxen | 16 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 16 | suppressed |
| Verapamil Er | Verapamil Hcl | 16 | suppressed |
| Bumetanide | Bumetanide | 15 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 15 | 14 |
| Levetiracetam | Levetiracetam | 15 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 14 | suppressed |
| Desloratadine | Desloratadine | 14 | suppressed |
| Estradiol | Estradiol | 14 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 14 | suppressed |
| Fluconazole | Fluconazole | 14 | suppressed |
| Mirtazapine | Mirtazapine | 14 | suppressed |
| Nystatin | Nystatin | 14 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 13 | suppressed |
| Epinephrine | Epinephrine | 13 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 13 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 13 | suppressed |
| Mounjaro | Tirzepatide | 13 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 13 | suppressed |
| Clonazepam | Clonazepam | 12 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 12 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 12 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 12 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 12 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 12 | 11 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 12 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 11 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 11 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 11 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 11 | suppressed |
| Ranolazine Er | Ranolazine | 11 | suppressed |
| Sotalol | Sotalol Hcl | 11 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 11 | suppressed |
| Xarelto | Rivaroxaban | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error